Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to -$9.9 million.

  • Assembly Biosciences' Other Working Capital Changes fell 4429.51% to -$9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.1 million, marking a year-over-year decrease of 13233.05%. This contributed to the annual value of -$13.3 million for FY2024, which is 11590.93% down from last year.
  • Latest data reveals that Assembly Biosciences reported Other Working Capital Changes of -$9.9 million as of Q3 2025, which was down 4429.51% from -$9.6 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Other Working Capital Changes peaked at $86.3 million during Q4 2023, and registered a low of -$9.9 million during Q3 2025.
  • Over the past 5 years, Assembly Biosciences' median Other Working Capital Changes value was -$982000.0 (recorded in 2021), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Assembly Biosciences' Other Working Capital Changes skyrocketed by 944788.73% in 2023, and later crashed by 67432.13% in 2024.
  • Quarter analysis of 5 years shows Assembly Biosciences' Other Working Capital Changes stood at -$4.3 million in 2021, then soared by 78.58% to -$923000.0 in 2022, then surged by 9447.89% to $86.3 million in 2023, then tumbled by 90.88% to $7.9 million in 2024, then crashed by 225.52% to -$9.9 million in 2025.
  • Its Other Working Capital Changes was -$9.9 million in Q3 2025, compared to -$9.6 million in Q2 2025 and -$9.4 million in Q1 2025.